Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: Preliminary data

Journal of Neuro-Oncology

Volumn 27, Issue 2, 1996, Pages 157-162

  Boiardi, Amerigo ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Loco regional chemotherapy; Mitoxantrone; Ommaya reservoir; Recurrent glioma

Indexed keywords

CARMUSTINE; CISPLATIN; DEXAMETHASONE; MITOXANTRONE; PHENYTOIN; PROCARBAZINE; VINCRISTINE;

ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TOLERABILITY; FEVER; GLIOBLASTOMA; HEADACHE; HUMAN; INTERSTITIUM; INTRAMUSCULAR DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; REGIONAL PERFUSION; TIME; TONIC CLONIC SEIZURE; TUMOR GROWTH; TUMOR RECURRENCE; VOMITING;

EID: 0030061896     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00177479     Document Type: Article

References (25)

1. Walker MD, Greed SB, Byar DP: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323-1329,1980
2. Perego P, Boiardi A, Carenini N, De Cesare M, Dolfini E, Giardinio R, Magnani I, Martignone, Silvani A, Soranzo C: Characterisation of an established human malignant glioblastoma cell line and its response to conventional drugs. J Cancer Res Clin Oncol 120: 585-592,1994
3. Nikkhah G, Tonn JC, Hoffman O, Kramer HP, Darling JL, Schachenmayr W: The MTT assay for chemosensitivity testing of human tumors of the central nervous system. J NeuroOncol 13: 13-24,1992
4. Stewart DJ, Hugenholtz H, Russell N, Richard MT, Benoit B, Maroun JA, Grahovac Z, Girard A, Nabwangu JF: Phase II study of novantrone (mitoxantrone hydrochloride) in adults with grade III-IV astrocytomas. In: Walker MD, Thomas DGT (ed) Biology of Brain Tumors, Martinus Nijhoff Publishers, Boston 411-413, 1986
5. Green RM, Stewart DJ, Hugenholtz H, Richard MT, Thibault M, Montpetit V: Human central nervous system and plasma pharmacology of mitoxantrone. J Neuro-Oncol 6: 75-83,1988
6. Macdonald DR, Cascino TL, Schold CS, Cairncross JG: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277-1280,1990
7. Garfield J, Dayan AD: Postoperative intracavitary chemotherapy of malignant gliomas, preliminary study using methotrexate. J Neurosurg 39: 315-322,1973
8. Garfield J, Dayan AD, Weller RO: Postoperative intracavitary chemotherapy of malignant supratentorial astrocytomas using BCNU Clin Oncol 1:213-222,1975
9. Nakazawa S, Ohwaki K, Shimura T, Itoh Y, Yaj ima K: A new treatment of malignant brain tumors - 1 - local injection of bleomycin. No Shinkei Geka 9: 1487-1493,1981
10. Morantz RA, Kimler BF, Vats TS, Henderson SD: Bleomycin and brain tumors. A review. J Neuro-Oncol 1:249-255, 1983
11. Nakazawa S, Itoh Y, Shimur AT, Matsumoto M, Yajiama K: A new treatment of malignant brain tumors - 2 - local injection of adriamycin. No Shinkei Geka 11: 821-827,1983
12. Tomita T: Interstitial chemotherapy for brain tumors: review. J Neuro-Oncol 10: 57-74, 1991
13. Kroin JS, Penn RD: Intracerebral chemotherapy: chronic microperfusion of cisplatin. Neurosurg 10: 349-354,1982
14. Kubo O, Himuro H, Inoue T, Tajima T, Ohyama T, Sakairi M, Kitamura K: Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites. No Shinkei Geka 14: 1189-1195, 1986
15. McKeran RO, Firth G, Oliver S, Uttley D, O'Laioire S: A potential application for the intracerebral injection of drugs entrapped within liposomes in the treatment of human cerebral gliomas. J Neurol Neurosurg Psychiat 48: 1213-1219, 1985
16. White RJ, Durr FE: Development of mitoxantrone. Investigational New Drugs 3: 85-93,1985
17. Moon TE, Salmon SE, White CS, Chen H-SG, Meyskens FL, Durie BGM, Alberts DS: Quantitative association between the in vitro human tumor stem cell assay and clinical response to cancer chemotherapy. Cancer Chemother Pharmacol 6: 211-218,1981
18. Alberts DS, Peng YM, Leigh S, Davis TP, Woodward DL: Deposition of mitoxantrone in cancer patients. Cancer Res 45: 1879-1884,1985
19. Posner LE, Dukart G, Goldberg J, Bernstein T, Cartwright K: Mitoxantrone: an overview of safety and toxicity. Investigational New Drugs 3: 123-132,1985
20. Peters FTM, Beljnen JH, Bokkel WW: Mitoxantrone extravasion injury. Cancer Treat Rep 71: 992-993,1987
21. Khory GG: Local tissue damage as a result of extravasion of mitoxantrone. Br Med J 292: 802-803,1986
22. Stewart DJ, Green RM, Mikhael NZ, Montpetit V, Thibaut M, Maroun JA: Human autopsy tissue concentrations of mitoxantrone. Cancer Treat Rep 70: 1255-1261,1986
23. Tonn JC, Schonmary R, Braun R, Kraemer HP, Ehninger G: Brain tissue concentration of mitoxantrone in the rat in relation to in vitro chemosensitivity of malignant human intracranial tumors, preliminary results. J Chemother 1:1181-1182,1989
24. Boiardi A, Silvani A, Milanesi I, Broggi G, Fariselli L: Efficacy of '8-drugs-in-one-day' combination treatment of recurrent GBM patients. J Neuro-Oncol 12: 153-158,1992
25. Kimler FB: The 9L rat brain tumor model for pre-clinical investigation of radiation chemotherapy interactions. J Neuro-Oncol 20: 103-109,1994